CellRapeutics™ Leukopak from Breast Cancer Donor (XS-0426-XU230)

Name: CellRapeutics™ Leukopak from Breast Cancer Donor
SKU: XS-0426-XU230
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Harvested from donors with confirmed breast adenocarcinoma, this Leukopak contains a diverse pool of peripheral immune cells influenced by the presence of a solid tumor. The collection includes circulating tumor-associated macrophages, myeloid-derived suppressor cells, and tumor-primed lymphocytes. It is specifically designed for researchers analyzing systemic immunosuppression, developing CAR-T/NK therapies, and identifying biomarkers for cancer immuno-editing.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Breast Cancer Donor

Cat. No.
XS-0426-XU230

Donor Age
Middle-Aged, Senior

Donor Health
Donors are diagnosed with breast adenocarcinoma. The immune environment reflects host-tumor interactions, featuring potential alterations in myeloid-derived suppressor cell ratios and tumor-responsive lymphocyte populations.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized to protect Rare Circulating Tumor Cells and maintain the cytotoxic potency of TIL-precursors/NK cells.

Additional Donor Information
Each lot features a Leukopak from donors with breast cancer. High-volume cell yields support the development of cell therapies and the study of peripheral immune suppression.

Clinical Profile
Molecular subtype, TNM stage, and details of surgical and systemic therapy.

Additional Information

Medication History
Available upon request. Records of chemotherapy, endocrine therapy, targeted therapies, and history of surgical or radiation interventions.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Breast Cancer Donor, Leukopak, Breast Cancer

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Breast Cancer Donor (XS-0426-XU230). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.